Temporarily successful eradication therapy in acquired haemophilia with high inhibitor titer: a case report with a new protocol.
Ilonczai
Péter
P
University of Debrecen, Medical and Health Science Center, 2nd Department of Medicine, Division of Haemostasis, 4032, Nagyerdei krt. 98. Debrecen, Hungary.
Schlammadinger
Agota
A
Oláh
Zsolt
Z
Rázsó
Katalin
K
Bereczky
Zsuzsanna
Z
Boda
Zoltán
Z
D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D001777:Blood Coagulation; D003029:Coagulants / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006470:Hemorrhage / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D010314:Partial Thromboplastin Time; D011517:Prothrombin Time; D013918:Thrombin Time; D014750:Vincristine / Q000627:therapeutic use; D014841:von Willebrand Factor / Q000276:immunology / Q000627:therapeutic use
D001323:Autoantibodies; D003029:Coagulants; D007166:Immunosuppressive Agents; D014841:von Willebrand Factor; D014750:Vincristine; D003907:Dexamethasone; C078147:F8 protein, human; D005169:Factor VIII